BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 25913415)

  • 1. DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift.
    de Goede AL; Andeweg AC; van den Ham HJ; Bijl MA; Zaaraoui-Boutahar F; van IJcken WF; Wilgenhof S; Aerts JL; Gruters RA; Osterhaus AD;
    Vaccine; 2015 Jun; 33(25):2922-9. PubMed ID: 25913415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells.
    Macatangay BJ; Riddler SA; Wheeler ND; Spindler J; Lawani M; Hong F; Buffo MJ; Whiteside TL; Kearney MF; Mellors JW; Rinaldo CR
    J Infect Dis; 2016 May; 213(9):1400-9. PubMed ID: 26647281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
    Vanham G; Van Gulck E
    Retrovirology; 2012 Sep; 9():72. PubMed ID: 22958464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular immune signatures of HIV-1 vaccines in human PBMCs.
    Monaco A; Marincola FM; Sabatino M; Pos Z; Tornesello ML; Stroncek DF; Wang E; Lewis GK; Buonaguro FM; Buonaguro L
    FEBS Lett; 2009 Sep; 583(18):3004-8. PubMed ID: 19665024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection.
    Kazer SW; Aicher TP; Muema DM; Carroll SL; Ordovas-Montanes J; Miao VN; Tu AA; Ziegler CGK; Nyquist SK; Wong EB; Ismail N; Dong M; Moodley A; Berger B; Love JC; Dong KL; Leslie A; Ndhlovu ZM; Ndung'u T; Walker BD; Shalek AK
    Nat Med; 2020 Apr; 26(4):511-518. PubMed ID: 32251406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients.
    Adamik J; Munson PV; Maurer DM; Hartmann FJ; Bendall SC; Argüello RJ; Butterfield LH
    Nat Commun; 2023 Nov; 14(1):7211. PubMed ID: 37938561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Molecular Signatures of Aging in Healthy and HIV-Infected Individuals.
    Rinaldi S; Pallikkuth S; De Armas L; Richardson B; Pan L; Pahwa R; Williams S; Cameron M; Pahwa S
    J Acquir Immune Defic Syndr; 2022 Feb; 89(Suppl 1):S47-S55. PubMed ID: 35015745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
    Martin Lluesma S; Graciotti M; Chiang CL; Kandalaft LE
    Vaccines (Basel); 2018 Nov; 6(4):. PubMed ID: 30477198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fight-or-flight response is associated with PBMC expression profiles related to immune defence and recovery in swine.
    Oster M; Scheel M; Muráni E; Ponsuksili S; Zebunke M; Puppe B; Wimmers K
    PLoS One; 2015; 10(3):e0120153. PubMed ID: 25793368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations.
    Nouri N; Cao RG; Bunsow E; Nehar-Belaid D; Marches R; Xu Z; Smith B; Heinonen S; Mertz S; Leber A; Smits G; van der Klis F; Mejías A; Banchereau J; Pascual V; Ramilo O
    Nat Commun; 2023 Dec; 14(1):7976. PubMed ID: 38042900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive Cellular Inflammation from Vaccination.
    West J Med Phys Sci; 1829; 3(1):158-159. PubMed ID: 38080523
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 and interferons: who's interfering with whom?
    Doyle T; Goujon C; Malim MH
    Nat Rev Microbiol; 2015 Jul; 13(7):403-13. PubMed ID: 25915633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to guide the antibody affinity maturation process.
    Doria-Rose NA; Joyce MG
    Curr Opin Virol; 2015 Apr; 11():137-47. PubMed ID: 25913818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.
    Carlsson RM; Gustafsson L; Hallander HO; Ljungman M; Olin P; Gothefors L; Nilsson L; Netterlid E
    Vaccine; 2015 Jul; 33(31):3717-25. PubMed ID: 26057135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals.
    Fehér C; Pastor-Lbáñez R; Leal L; Plana M; Arnedo M; van den Ham HJ; Andeweg AC; Gruters RA; Díez-Fuertes F; Alcamí J; Aloy P; García F
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine.
    Pastor-Ibáñez R; Díez-Fuertes F; Sánchez-Palomino S; Alcamí J; Plana M; Torrents D; Leal L; García F
    Vaccines (Basel); 2021 Jun; 9(7):. PubMed ID: 34202658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response.
    Leal L; Fehér C; Richart V; Torres B; García F
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32764508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.
    de Jong W; Aerts J; Allard S; Brander C; Buyze J; Florence E; van Gorp E; Vanham G; Leal L; Mothe B; Thielemans K; Plana M; Garcia F; Gruters R;
    Trials; 2019 Jun; 20(1):361. PubMed ID: 31208472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.
    Reis EC; da Silva LT; da Silva WC; Rios A; Duarte AJ; Oshiro TM; Crovella S; Pontillo A
    Hum Vaccin Immunother; 2018; 14(8):1995-2002. PubMed ID: 29641325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.
    van den Ham HJ; Cooper JD; Tomasik J; Bahn S; Aerts JL; Osterhaus ADME; Gruters RA; Andeweg AC;
    PLoS One; 2018; 13(2):e0192278. PubMed ID: 29389978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.